《Huge News for CVS Stock Investors》
AI 摘要 · 据报道,CVS 计划分拆其零售药房业务,该业务面临门店客流减少和工资上涨的压力;说话者认为这是积极进展,使其对 CVS 的长期前景更为乐观,并以较低的信心和把握重申买入评级。CVS 股价为 91.41 美元,低于其超过 120 美元的公允价值估计;其 10.72 倍的远期市盈率低于华尔街约 12% 的每股收益增长预期,但超过 740 亿美元的长期债务是主要担忧。
CVS 股票的投资者迎来了重大消息:据彭博社报道,该公司正在讨论剥离其零售药房业务的计划。这可能是一项规模巨大的工程,因为无论从过去十二个月的营收还是现有门店数量来看,CVS Health 都是全球最大的公司之一。
We have huge news for CVS stock investors, as Bloomberg reports that the company is discussing plans to spin off its retail pharmacy business. This could be a huge undertaking, given that CVS Health is one of the largest companies in the world, both in terms of its revenue over the past twelve months and the number of its existing locations.